Apr 27, 2012 | Seeking Alpha
A.P. Pharma: Unusual Potential For A Small Company
In this report, I have made projections for sales, earnings and cash flow for A.P. Pharma through 2016.
A.P. Pharma, Inc. Announces Fourth Quarter and Full Year 2011...
A.P. Pharma, Inc. Announces Fourth Quarter and Full Year 2011 Financial Results and Provides Update on APF530 REDWOOD CITY, CA-- - A.P. Pharma, Inc.
SADIF Analytics releases new summary due diligence reports for American stocks
Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering the following companies: Report Summary for: Agnico-Eagle Mines Limited is an average quality company with a neutral outlook.
A.P. Pharma's third quarter net loss increases to $4.2 million
A.P. Pharma, Inc. , a specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2011 and highlighted its recent corporate progress.
A.P. Pharma second quarter net loss decreases to $1.9 million
A.P. Pharma, Inc. , a specialty pharmaceutical company, today reported financial results for its second quarter ended June 30, 2011 and highlighted its recent corporate progress.